TB drug, rifabutin, active against Acinetobacter baumannii in the lab

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body. The antibiotic, rifabutin, is highly active" in fighting multidrug-resistant Acinetobacter baumannii, a significant cause of life-threatening infections in medical facilities, researchers found. The [...]

The post TB drug, rifabutin, active against Acinetobacter baumannii in the lab appeared first on Outbreak News Today.